Some transplant programs consider the lack of health insurance as a contraindication to living kidney donation. Still, prior studies have shown that many adults are uninsured at time of donation. We extend the study of donor health insurance status over a longer time period and examine associations between insurance status and relevant sociodemographic and health characteristics. We queried the United Network for Organ Sharing/Organ Procurement and Transplantation Network registry for all living kidney donors (LKDs) between July 2004 and July 2015. Of the 53 724 LKDs with known health insurance status, 8306 (16%) were uninsured at the time of donation. Younger (18 to 34 years old), male, minority, unemployed, less educated, unmarried LKDs and those who were smokers and normotensive were more likely to not have health insurance at the time of donation. Compared to those with no health risk factors (i.e. obesity, smoking, hypertension, estimated glomerular filtration rate <60, proteinuria) (14%), LKDs with 1 (18%) or ≥2 (21%) health risk factors at the time of donation were more likely to be uninsured (p < 0.0001). Among those with ≥2 health risk factors, blacks (28%) and Hispanics (27%) had higher likelihood of being uninsured compared to whites (19%; p < 0.001). Study findings underscore the importance of providing health insurance benefits to all previous and future LKDs.
Introduction
While guidelines exist for the evaluation of living kidney donors (LKDs) (1, 2) , considerable variation persists in the surgical, medical, and psychosocial criteria used by transplant programs in the United States to determine donation eligibility (3) (4) (5) (6) . One characteristic that remains controversial in determining donation eligibility is the presence or absence of health insurance in the potential LKD (4) (5) (6) (7) (8) (9) (10) . In a survey of U.S. kidney transplant programs, the lack of health insurance in the donor was an absolute and relative contraindication to donation in 15% and 42% of programs, respectively (4) .
Some programs may not require LKDs to have their own health insurance because the costs associated with the donation evaluation, surgery, hospitalization, follow-up, and short-term complications are covered by the transplant recipient's health insurance in most instances. Moreover, the incidence of donation-related consequences is relatively low (11) (12) (13) (14) , and requiring LKDs to have health insurance that they are likely to never activate for donation-related health concerns may be seen as overly restrictive, particularly if the LKD is willing to accept this risk. However, it has been shown that LKDs in the United States incur healthcare costs both before and after donation (15, 16) . These may include costs for routine health screening that is necessary for donation evaluation but not covered by the recipient's health insurance (e.g. mammogram, colonoscopy) and for evaluation and treatment of newly discovered health problems during the evaluation. Other potential healthcare costs may include outpatient appointments and laboratory testing to satisfy the donor follow-up regulatory requirements for 2 years after donation, rehabilitation services, and the evaluation and treatment of complications not covered by the recipient's insurance (10, 16, 17) . It is recognized, of course, that health insurance status is not static for many adults in the United States-LKDs insured at the time of evaluation and donation may become uninsured in the 2 years following donation, while uninsured LKDs may subsequently acquire health insurance (18) .
Approximately 32% of kidney transplants in the United States are performed using kidneys from healthy living donors (19) . The number of LKDs in the United States peaked in 2004 and has declined in the last decade (20) .
There were only 5538 LKDs in 2015, which is 17% fewer than the 6647 donors in 2004 (http://optn.transplant. hrsa.gov). Considering the decline in LKDs in the context of increasing volume of transplant candidates, it is possible that transplant programs have become less stringent about the need for potential donors to have health insurance at the time of donation. Conversely, emerging data regarding the healthcare costs incurred by LKDs (15, 16) and the policy changes requiring programs to report clinical follow-up data on their donors (1) may have triggered some programs to require health insurance at time of donation.
Health insurance trends in LKDs are an important topic of scientific inquiry. More than 36 million adults (10%) in the United States are uninsured (21) . The proportion of uninsured is highest in young adults (ages 19 to 34 years old), adults with low income, and African Americans, three groups that have seen a precipitous drop in the rate of living kidney donation in the last decade (20) . Moreover, those without health insurance are less likely to have an identified primary care physician, undergo routine healthcare screening, seek medical evaluation of new-onset physical symptoms and psychological distress, follow through with recommended care following a diagnosis of a chronic health condition, fill prescriptions, and live as long compared to those with health insurance (22) .
Gibney et al (23) previously examined health insurance status of LKDs between July 2004 and September 2006 and found that 18% were uninsured at time of donation. Also, LKDs who were younger, male, and minorities had higher rates of being uninsured. In the current study, we sought to extend the prior work of Gibney et al (23) by examining the temporal health insurance trends at the time of donation in LKDs between July 2004 and July 2015. Additionally, we examined whether LKD health insurance status was associated with sociodemographic, health, and donation characteristics.
Methods
We obtained data from the United Network for Organ Sharing/Organ Procurement and Transplantation Network (UNOS/OPTN) registry for all LKDs between July 2004 and July 2015. July 2004 was selected as the start point since health insurance status was not formally collected by the UNOS/OPTN prior to that date. The primary variable of interest was known LKD health insurance status at the time of donation. Transplant programs report only whether the donor has health insurance ("insured," "uninsured," or "unknown insurance status"), not the specific policy type. t-tests and chi-square statistics were calculated to compare the characteristics of LKDs with known insurance status (i.e. insured or uninsured) to those with unknown insurance status. The latter group was then excluded from subsequent analyses.
Fisher exact and chi-square tests were used to assess the relationship between LKD health insurance status and sociodemographic (age, sex, race/ethnicity, working status, education level, and marital status) and health (obesity, current smoking, hypertension, estimated glomerular filtration rate [eGFR] < 60, and proteinuria) characteristics. A health risk score was calculated and we examined its relationship to health insurance status. The health risk score was the simple sum of five variables, the presence of each at the time of donation, yielding 1 point for a score ranging from 0 to 5. The five variables were obesity (body mass index > 30 kg/m 2 ), cigarette smoking, hypertension, eGFR < 60, and proteinuria (positive urine protein by dipstick). eGFR was calculated using the Modification of Diet in Renal Disease equation (24) . We also examined the association between health insurance status and UNOS region, as well as for any differences in health insurance status between the nonelderly (<65 years old) adult general population (22) and LKDs in each UNOS region. Next, we studied whether health insurance status predicted likelihood of having serum creatinine (SCr) in the UNOS/OPTN registry at the 6-, 12-, and 24-month follow-up assessments, controlling for age, sex, race/ethnicity, working status, education level, and marital status. Finally, we conducted secondary analyses to examine the relationship between health insurance status and donation events that occurred within the first 6 weeks following surgery, including laparoscopic to open nephrectomy conversion, re-operation, hospital readmission, complications requiring intervention, and new-onset hypertension.
All analyses were conducted using SPSS (SPSS Inc., Chicago, IL). To reduce the likelihood of Type I error rate associated with very large samples and multiple comparisons, statistical significance was set at p < 0.001. We received a determination of exempt status from the Committee on Clinical Investigation at Beth Israel Deaconess Medical Center (Protocol #2015P-000373).
Results
There was a total of 66 987 LKDs between July 2004 and July 2015. We excluded LKDs who were <18 years old (n = 4), did not reside in the United States (n = 573), and whose health insurance status was unknown (n = 12 686), resulting in a final sample of 53 724 LKDs. Table 1 summarizes the sociodemographic, health status, and donation characteristics of this cohort. Mean age was 41.8 (AE11.5) years and the majority were female (61%), non-Hispanic white (71%), employed (81%), married (63%), had more than a high school education (73%), and biologically related to the recipient (55%). LKDs excluded due to unknown insurance status were more likely to be younger, male, black, have less than college education, and obese than those with known health insurance status (p values < 0.0001).
Of the 53 724 LKDs in the analysis cohort, 8306 (16%) did not have health insurance at the time of donation. Figure 1 Among LKDs (n = 1235) with a hospital readmission in the first 6 weeks after discharge, 236 (19%) were uninsured (vs. 15% of those who did not have a readmission, p < 0.001). Of the readmissions among uninsured LKDs, the most common reasons were wound infection (10%), bowel obstructions (8%), fever (3%), vascular complications (1%), and other complications (70%; e.g. abdominal pain, dehydration, nausea and vomiting, pain, urinary tract infection). Uninsured LKDs did not have significantly higher rates of conversion from laparoscopic to open nephrectomy, re-operation, complications requiring intervention, or new-onset hypertension within the first 6 weeks following donation (p values > 0.05).
We also examined whether health insurance status was associated with the occurrence of complications or hospital readmissions related to donation, new-onset hypertension requiring medication, or positive urine protein between the 6-week and 2-year follow-up assessments. Among LKDs (n = 3328) with proteinuria at any point during the 2-year follow-up period, 555 (17%) were uninsured (vs. 15% of those who did not have proteinuria, p < 0.04). Also, among those (n = 1038) with newly diagnosed hypertension at any point during the 2-year followup period, 123 (12%) were uninsured (vs. 16% of those who did not have hypertension, p < 0.001).
Discussion
In the United States, 16% of LKDs in the last decade lacked health insurance at the time of donation, which is comparable to the percentage of uninsured adults in the general nonelderly adult population (15%) (22) . This suggests that the uninsured are not over-represented among LKDs relative to their proportion in the general population, thereby not assuming a higher than expected living donation burden. Also, the percentage of uninsured LKDs has steadily declined in recent years, for which there may be several explanations. First, there may be an increased reluctance on the part of transplant programs to accept uninsured donors. More than half of kidney transplant programs surveyed in the United States viewed the lack of health insurance as an absolute or relative contraindication to donation (4). However, it is unknown whether those survey findings from a decade ago reflect current donor eligibility criteria and selection practices. Second, changing LKD demographics may account for this decline in uninsured donors. Since the peak volume in 2004, living kidney donation has decreased by 30% in younger (<35 years old) adults and increased by 35% in those 50 years old and older (25) . A shift toward older donors who are more likely to be insured may also account for the overall change in health insurance coverage among LKDs. Third, changing health insurance patterns in the United States might also be a contributing factor to what we are observing in LKDs. For instance, the Patient Protection and Affordable Care Act (ACA) has contributed to a decrease in nonelderly adults without health insurance, since its marketplace enrollment began in October 2013. Compared to the 2 years prior, the percentage of LKDs without insurance dropped from 15% to 11% in the 2 years after ACA marketplace enrollment began.
Despite the favorable decline in the percentage of uninsured LKDs, the lack of health insurance in 16% of LKDs (or even 9% of LKDs, if examining 2015 data only) represents an "at-risk" population of several hundred donors per year in the United States. Living donation in the absence of health insurance may cause additional financial hardship for LKDs who may incur healthcare expenses that are not covered by the recipient's health insurance policy (15) (16) (17) . Additionally, donation may adversely impact the LKD's future health insurability. Boyarsky et al (26) found that 7% of LKDs reported problems changing or initiating health insurance after donation. Others have reported a smaller percentage of LKDs being denied health insurance (18, 27) , but its occurrence can have downstream social, financial, and health consequences for donors. While ACA made it illegal for insurance companies to refuse health insurance to those with pre-existing conditions (including LKDs) beginning January 1, 2014 (28,) there is the possibility that the ACA-or some of its components-may be repealed in the future (29) . The lack of health insurance at the time of donation also may affect compliance with follow-up for the 2 years required by UNOS/OPTN and beyond. Consistent with data reported by Schold et al (30) , we found that uninsured adults at time of donation were less likely to have 6-, 12-, and 24-month SCr values reported in the UNOS/OPTN database. Failure to attend to required follow-up poses risk for both the donor (i.e. lack of health assessment) and transplant program (i.e. failure to meet minimum thresholds for donor follow-up and probationary disposition) (1). Improved donor followup care is a unifying call to action within the transplant community (8, (30) (31) (32) (33) (34) ; however, a standardized approach for how to deliver (and pay for) such care to uninsured LKDs is lacking.
Perhaps most troubling is our finding that LKDs with two or more health risk factors (i.e. medically complex donors) are less likely to have insurance at the time of donation compared to those with no risk factors. Donors with obesity, hypertension, cigarette smoking, low eGFR, and/or proteinuria at time of donation are at highest need for consistent insurance coverage to facilitate routine monitoring in the months and years following donation. However, laboratory and provider fees for routine surveillance may be prohibitive for those without insurance. Indeed, lack of health insurance has been shown to be a barrier to accessing healthcare, associated with poorer health outcomes, and a risk factor for premature death from preventable causes in the general population (21, 22, 35, 36) . In the context of emerging long-term outcomes for LKDs (37, 38) , accepting uninsured medically complex LKDs raises critical ethical questions about donor eligibility criteria.
Racial/ethnic minority LKDs were less likely than whites to have insurance. While this same disparity exists in the general population, we were surprised to find that minority LKDs had a substantially higher rate of being uninsured relative to general population rates within their own race/ethnicity (20% vs. 13% for blacks, 30% vs. 21% for Hispanics) (21) . Also, we found that the percentage of uninsured blacks and Hispanics with two or more health risk factors is much higher than for uninsured whites with the same health risk factors. Living kidney donation in minorities, particularly blacks, has declined sharply in recent years, further exacerbating disparities in rates of live donor kidney transplantation (20, 25, 39) . Minorities are likely to have more medical issues that regulations simply require programs to inform potential LKDs that donation may make it more difficult to obtain or maintain health insurance in the future and that health problems related to donation may not be covered by the donor's current or future health insurance (1 Another important limitation of the database is that health insurance status is captured only at the time of donation and changes in status-and its relationship to sociodemographic characteristics and outcomes-after donation are unknown.
In conclusion, a small but significant percentage of LKDs do not have health insurance at time of donation. While evaluation and treatment of short-term donation-related complications and surveillance testing may be covered by the recipient's health insurance, LKDs who remain uninsured following donation may be at risk for higher financial impact if complications occur. Particularly troubling is that lack of insurance is more common in LKDs with known health disparities (e.g. minorities, least educated) and those who have two or more pre-existing health risk factors (e.g. obesity, smoking, hypertension, low eGFR, proteinuria). Data from this study should be considered in discussions regarding the provision of health insurance benefits to previous and future LKDs in the United States (8, 10, 23, 42, 43) .
